Parkinson disease (PD) is the second most common neurodegenerative disease, and it cannot be completely cured by current medications. In this study, DJ-1 protein was administrated into medial forebrain bundle of PD model rats those had been microinjected with 6-hydroxydopamine (6-OHDA) or MG-132. We found that DJ-1 protein could reduce apomorphine-induced rotations, inhibit reduction of dopamine contents and tyrosine hydroxylase levels in the striatum, and decrease dopaminergic neuron death in the substantia nigra. In 6-OHDA lesioned rats, uncoupling protein-4, uncoupling protein-5 and superoxide dismutase-2 (SOD2) mRNA and SOD2 protein were increased when DJ-1 protein was co-injected. Simultaneously, administration of DJ-1 protein reduced ...
BACKGROUND: Parkinson's disease (PD) is a neurodegenerative pathology whose molecular etiopathogene...
Drugs currently used for treating Parkinson's disease patients provide symptomatic relief witho...
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a loss of dopaminergic neu...
Background: Dopaminergic degeneration is a major finding in brains of patients with Parkinson's dise...
AbstractParkinson's disease (PD) is caused by dopaminergic cell death in the substantia nigra, leadi...
Parkinson\u27s disease (PD) is a neurodegenerative disorder that involves a loss of dopaminergic neu...
Parkinson’s disease (PD) is the most common movement neurodegenerative disease affecting approximate...
Parkinson’s disease (PD) is caused by dopaminergic neuronal death in the substantia nigra, resulting...
DJ-1 protein has multiple specific mechanisms to protect dopaminergic neurons against neurodegenerat...
Parkinson’s disease (PD) is a common age-related neurodegenerative disorder. Dopamine neurotoxicity,...
BACKGROUND Dopaminergic degeneration is a major finding in brains of patients with Parkinson's disea...
Drugs currently used for treating Parkinson's disease patients provide symptomatic relief without al...
(SN) of PD patients. A-syn has neuroprotective chaperone-like and antioxidant functions and is invo...
Although a loss-of-function mutation has been identified in familial Parkinson's disease PARK7, the ...
Several mutations in the gene coding for DJ-1 have been associated with early onset forms of parkins...
BACKGROUND: Parkinson's disease (PD) is a neurodegenerative pathology whose molecular etiopathogene...
Drugs currently used for treating Parkinson's disease patients provide symptomatic relief witho...
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a loss of dopaminergic neu...
Background: Dopaminergic degeneration is a major finding in brains of patients with Parkinson's dise...
AbstractParkinson's disease (PD) is caused by dopaminergic cell death in the substantia nigra, leadi...
Parkinson\u27s disease (PD) is a neurodegenerative disorder that involves a loss of dopaminergic neu...
Parkinson’s disease (PD) is the most common movement neurodegenerative disease affecting approximate...
Parkinson’s disease (PD) is caused by dopaminergic neuronal death in the substantia nigra, resulting...
DJ-1 protein has multiple specific mechanisms to protect dopaminergic neurons against neurodegenerat...
Parkinson’s disease (PD) is a common age-related neurodegenerative disorder. Dopamine neurotoxicity,...
BACKGROUND Dopaminergic degeneration is a major finding in brains of patients with Parkinson's disea...
Drugs currently used for treating Parkinson's disease patients provide symptomatic relief without al...
(SN) of PD patients. A-syn has neuroprotective chaperone-like and antioxidant functions and is invo...
Although a loss-of-function mutation has been identified in familial Parkinson's disease PARK7, the ...
Several mutations in the gene coding for DJ-1 have been associated with early onset forms of parkins...
BACKGROUND: Parkinson's disease (PD) is a neurodegenerative pathology whose molecular etiopathogene...
Drugs currently used for treating Parkinson's disease patients provide symptomatic relief witho...
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a loss of dopaminergic neu...